Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Published Erratum
. 2021 Dec;6(6):100345.
doi: 10.1016/j.esmoop.2021.100345. Epub 2021 Dec 2.

Corrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273]

M Reck  1 , T-E Ciuleanu  2 , M Cobo  3 , M Schenker  4 , B Zurawski  5 , J Menezes  6 , E Richardet  7 , J Bennouna  8 , E Felip  9 , O Juan-Vidal  10 , A Alexandru  11 , H Sakai  12 , A Lingua  13 , F Reyes  14 , P-J Souquet  15 , P De Marchi  16 , C Martin  17 , M Pérol  18 , A Scherpereel  19 , S Lu  20 , L Paz-Ares  21 , D P Carbone  22 , A Memaj  23 , S Marimuthu  23 , X Zhang  23 , P Tran  23 , T John  24
Affiliations
Published Erratum

Corrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273]

M Reck et al. ESMO Open. 2021 Dec.
No abstract available

PubMed Disclaimer

Figures

Figure 4
Figure 4
Grade 3/4 TRAE onset by treatment cycle. Chemo, chemotherapy; IPI, ipilimumab; NIVO, nivolumab; TRAE, treatment-related adverse event. Includes events reported between first dose and 30 days after last dose of study therapy. Overlapping TRAEs with same preferred term per patient were clustered and reported as unique TRAE. Patient is considered at risk in a pooled two-cycle reporting interval if exposed to any study drug in that interval. Patient is counted once in each TRAE grade category for each pooled two-cycle reporting interval with TRAE incidence.
See this image and copyright information in PMC

Erratum for

Publication types